secwatch.observer — SEC 8-K summary
======================================

Issuer:     LENZ Therapeutics, Inc. (LENZ)
CIK:        0001815776
Form:       8-K
Filed at:   2022-06-23T23:59:59+00:00
Accession:  0001193125-22-180184
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Graphite Bio stockholders elect three Class I directors and ratify auditor at 2022 Annual Meeting
--------------------------------------------------------------------------------

- Stockholders elected Jerel Davis, Perry Karsen, and Joseph Jimenez as Class I directors; each received >37M votes for, ~3M withheld.
- Ratification of Deloitte & Touche as independent auditor for FY2022 passed with ~42.2M for, 5,230 against, 9,929 abstentions.
- Total shares present or represented: 42,241,989 out of 57,970,110 shares entitled to vote.
- Broker non-votes: 1,680,515 on director election; none on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815776/000119312522180184/0001193125-22-180184-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815776/000119312522180184/d350734d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-180184

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer